Catarig AM - Search Results

1

Design and Baseline Characteristics of the STRIDE Trial: evaluating Semaglutide in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes.

Bonaca MP, Catarig AM, Hansen Y, Houlind K, Ramesh CK, Ludvik B, Nordanstig J, Rasouli N, Sourij H, Verma S. Bonaca MP, et al. Among authors: catarig am. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 18:pvae071. doi: 10.1093/ehjcvp/pvae071. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39424598

2

Impact of Manufacturing Process and Compounding on Properties and Quality of Follow-On GLP-1 Polypeptide Drugs.

Hach M, Engelund DK, Mysling S, Mogensen JE, Schelde O, Haselmann KF, Lamberth K, Vilhelmsen TK, Malmstrøm J, Højlys-Larsen KB, Rasmussen TS, Borch-Jensen J, Mortensen RW, Jensen TMT, Kesting JR, Catarig AM, Asgreen DJ, Christensen L, Staby A. Hach M, et al. Among authors: catarig am. Pharm Res. 2024 Oct;41(10):1991-2014. doi: 10.1007/s11095-024-03771-6. Epub 2024 Oct 8. Pharm Res. 2024. PMID: 39379664

3

Adherence to glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes mellitus: A nationwide registry study.

Lassen MCH, Johansen ND, Modin D, Catarig AM, Vistisen BK, Amadid H, Zimmermann E, Gislason G, Biering-Sørensen T. Lassen MCH, et al. Among authors: catarig am. Diabetes Obes Metab. 2024 Nov;26(11):5239-5250. doi: 10.1111/dom.15872. Epub 2024 Aug 31. Diabetes Obes Metab. 2024. PMID: 39215626

4

Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme.

Yale JF, Major-Pedersen A, Catarig AM, Jain R, Menzen M, Holmes P. Yale JF, et al. Among authors: catarig am. Diabetes Obes Metab. 2024 Oct;26(10):4429-4440. doi: 10.1111/dom.15794. Epub 2024 Aug 8. Diabetes Obes Metab. 2024. PMID: 39118222

5

Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort study.

Skriver C, Friis S, Knudsen LB, Catarig AM, Clark AJ, Dehlendorff C, Mørch LS. Skriver C, et al. Among authors: catarig am. Diabetologia. 2023 Nov;66(11):2007-2016. doi: 10.1007/s00125-023-05972-x. Epub 2023 Aug 3. Diabetologia. 2023. PMID: 37532786

6

Once-weekly semaglutide use in patients with type 2 diabetes: Results from the SURE France multicentre, prospective, observational study.

Mohammedi K, Belhatem N, Berentzen TL, Catarig AM, Potier L. Mohammedi K, et al. Among authors: catarig am. Diabetes Obes Metab. 2023 Jul;25(7):1855-1864. doi: 10.1111/dom.15045. Epub 2023 Mar 28. Diabetes Obes Metab. 2023. PMID: 36869853

7

Once-weekly semaglutide use in patients with type 2 diabetes: Real-world data from the SURE Italy observational study.

Napoli R, Berra C, Catarig AM, Di Loreto C, Donatiello E, Berentzen TL, Pitocco D, Giorgino F. Napoli R, et al. Among authors: catarig am. Diabetes Obes Metab. 2023 Jun;25(6):1658-1667. doi: 10.1111/dom.15020. Epub 2023 Mar 12. Diabetes Obes Metab. 2023. PMID: 36789682

8

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany.

Menzen M, Berentzen TL, Catarig AM, Pieperhoff S, Simon J, Jacob S. Menzen M, et al. Among authors: catarig am. Exp Clin Endocrinol Diabetes. 2023 Apr;131(4):205-215. doi: 10.1055/a-2007-2061. Epub 2023 Jan 4. Exp Clin Endocrinol Diabetes. 2023. PMID: 36599459 Free PMC article.

9

Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study.

Wolffenbuttel BHR, Brugts MP, Catarig AM, Clark A, Kok M, Lieverse AG, van Soest J. Wolffenbuttel BHR, et al. Among authors: catarig am. Adv Ther. 2023 Mar;40(3):920-933. doi: 10.1007/s12325-022-02385-x. Epub 2022 Dec 21. Adv Ther. 2023. PMID: 36542260 Free PMC article.

10

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes.

Lingvay I, Catarig AM, Lawson J, Chubb B, Gorst-Rasmussen A, Evans LM. Lingvay I, et al. Among authors: catarig am. Diabetes Ther. 2023 Jan;14(1):123-137. doi: 10.1007/s13300-022-01344-7. Epub 2022 Nov 25. Diabetes Ther. 2023. PMID: 36434159 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters